Company
Nuvation Bio Inc.
Nuvation Bio Inc. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Safusidenib | Phase 2 | Grade 2 IDH1-mutant Glioma |
Latest
No recent events.
Follow Nuvation Bio Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.